IA
ENZ

IndexIQ Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

IndexIQ Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-168,301
Closed -$1.37M – 690
2017
Q4 		$1.37M Buy
168,301
+64,750
+63% +$618K 0.05% 305
2017
Q3 		$1.08M Buy
103,551
+46,975
+83% +$521K 0.05% 199
2017
Q2 		$625K Buy
+56,576
New +$527K 0.03% 203

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IndexIQ Advisors's ENZ Position: Q1 2018 in Review

IndexIQ Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q1 2018, closing a stake of 168,301 shares — an estimated $1.37M sold.

IndexIQ Advisors first reported a position in ENZ in Q2 2017 and held it in 3 quarters. The position peaked at $1.37M in Q4 2017. 107 funds tracked by Wall St. Rank hold ENZ as of Q1 2018.

  • IndexIQ Advisors reported no remaining Enzo Biochem, Inc. position as of Q1 2018 after selling out during the quarter.
  • IndexIQ Advisors sold 168,301 Enzo Biochem, Inc. shares in Q1 2018, an estimated $1.37M.
  • IndexIQ Advisors first reported a position in Enzo Biochem, Inc. in Q2 2017 and held it in 3 quarters.
  • IndexIQ Advisors's Enzo Biochem, Inc. position peaked at $1.37M in Q4 2017.
  • 107 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2018.

Based on IndexIQ Advisors's 13F filing for Q1 2018, filed 15 May 2018.